NMES1
Normal mucosa of esophagus-specific gene 1 protein
Also known as: C15orf48, COXFA4L3, MIR147BHG, MISTRAV, MOCCI, NMES1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9C002
- Gene
- NMES1
- Ensembl
- ENSG00000166920
- Chromosome
- 15
- Canonical length
- 83 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene was first identified in a study of human esophageal squamous cell carcinoma tissues. Levels of both the message and protein are reduced in carcinoma samples. In adult human tissues, this gene is expressed in the the esophagus, stomach, small intestine, colon and placenta. Alternatively spliced transcript variants that encode the same protein have been identified. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
83 residues, UniProt reviewed canonical sequence.
>Q9C002|NMES1
1 MSFFQLLMKR KELIPLVVFM TVAAGGASSF AVYSLWKTDV ILDRKKNPEP WETVDPTVPQ
61 KLITINQQWK PIEELQNVQR VTKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NMES1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 867 nTPM
Expression across tissuesHPA
Tissue
- rectum: 867 nTPM
- colon: 808 nTPM
- small intestine: 321 nTPM
- esophagus: 162 nTPM
- testis: 120 nTPM
- stomach: 101 nTPM
Single-cell type
- esophageal apical cells: 5,881 nCPM
- colonocytes: 3,918 nCPM
- enterocytes: 2,604 nCPM
- enteric transient amplifying cells: 2,389 nCPM
- goblet cells: 1,330 nCPM
- enteric stem cells: 1,313 nCPM
Immune cell
- intermediate monocyte: 1.6 nTPM
- classical monocyte: 1.3 nTPM
- myeloid DC: 1.3 nTPM
- neutrophil: 0.8 nTPM
- total PBMC: 0.8 nTPM
- non-classical monocyte: 0.2 nTPM
Brain region
- cerebral cortex: 6.3 nTPM
- pons: 2.2 nTPM
- thalamus: 1.8 nTPM
- choroid plexus: 0.9 nTPM
- white matter: 0.8 nTPM
- medulla oblongata: 0.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.86
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NMES1 as an antibody target. Whether an autoantibody or antibody against NMES1 could matter depends on whether native NMES1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NMES1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NMES1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...